Cart
sales@molnova.com
Oxyberberine
CAS No. 549-21-3
Oxyberberine( Berlambine | 8-Oxoberberine | Ketoberberine )
Catalog No. M20465 CAS No. 549-21-3
Oxyberberine is isolated from the methanol extract of A. mexicana. It has been used to study the SW480 human colon cancer cell line.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 142 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxyberberine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxyberberine is isolated from the methanol extract of A. mexicana. It has been used to study the SW480 human colon cancer cell line.
-
DescriptionOxyberberine is isolated from the methanol extract of A. mexicana. It has been used to study the SW480 human colon cancer cell line.
-
In Vitro——
-
In Vivo——
-
SynonymsBerlambine | 8-Oxoberberine | Ketoberberine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number549-21-3
-
Formula Weight351.35
-
Molecular FormulaC20H17NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (47.45 mM)
-
SMILESCOc1ccc2cc3-c4cc5OCOc5cc4CCn3c(=O)c2c1OC
-
Chemical Name8-Berbinone 1313a-didehydro-910-dimethoxy-23-(methylenedioxy)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bajpai V Singh A Arya KRet al.Rapid screening for the adulterants of Berberis aristata using direct analysis in real-time mass spectrometry and principal component analysis for discrimination[J].Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(6):799-807
molnova catalog
related products
-
Oxynitidine
Oxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV. Oxynitidine can be used in the study of viral infections.
-
SEC inhibitor KL-2
SEC inhibitor KL-2 (KL-2) is a potent and selective inhibitor of the super elongation complex (SEC), showing a dose-dependent inhibitory effect on the AFF4-CCNT1 interaction with a Ki of 1.50 μM.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
